Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

PHASQ

PhaseBio Pharmaceuticals (CE) (PHASQ)

PhaseBio Pharmaceuticals Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:PHASQ

Date	Heure	Source	Titre	Symbole	Société
16/05/2024	22h32	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
16/05/2024	22h28	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
30/05/2023	22h03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
19/05/2023	22h19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
16/05/2023	22h23	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
03/04/2023	22h06	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
14/02/2023	23h07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
21/12/2022	12h10	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)
04/11/2022	21h44	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PHASQ	PhaseBio Pharmaceuticals Inc (CE)